Results 221 to 230 of about 861,631 (245)
Some of the next articles are maybe not open access.
Minor Histocompatibility Antigens
The Cancer Journal, 2004Minor histocompatibility antigens have to be considered as key molecules in the stem cell-based immunotherapy of malignancies. Allogeneic stem cell transplantation (SCT) is a well-established and effective therapy for advanced hematologic malignancies.
openaire +2 more sources
Molecular Typing Methods for Minor Histocompatibility Antigens
2013Minor histocompatibility (H) antigen mismatching leads to clinically relevant alloimmune reactivity. Depending on the tissue expression pattern of the involved minor H antigens, the immune response may either cause graft-versus-host disease and a graft-versus-tumor effect or lead to only a graft-versus-leukemia effect. Thus, identification of recipient-
openaire +2 more sources
IMMUNE RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS
Transplantation, 1972L W, Schierman, R A, McBride
openaire +2 more sources
Risk assessment in haematopoietic stem cell transplantation: Minor histocompatibility antigens
Best Practice and Research in Clinical Haematology, 2007Eric Spierings +2 more
exaly
Genetic control of minor histocompatibility antigens in the mouse
Survey of Immunologic Research, 1984R E, Click, M M, Azar
openaire +2 more sources